Global Narcolepsy Therapeutics Market Analysis 2016-2024 and Forecast 2024-2034
Snapshot
The global Narcolepsy Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Narcolepsy Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.)
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.)
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Shire
Ligand Pharmaceuticals, Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.)
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Region Coverage (Regional Production, Demand & Forecast by Countries etc.)
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Content
Table of Contents
Table of Contents
1 Industry Overview
1.1 Narcolepsy Therapeutics Industry
Figure Narcolepsy Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Narcolepsy Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Narcolepsy Therapeutics
1.2.2 Downstream
Table Application Segment of Narcolepsy Therapeutics
Table Global Narcolepsy Therapeutics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Narcolepsy Therapeutics Market by Type
3.1 By Type
3.1.1 Central nervous system stimulants
Table Major Company List of Central nervous system stimulants
3.1.2 Sodium Oxybate
Table Major Company List of Sodium Oxybate
3.1.3 Selective Serotonin Reuptake Inhibitor (SSRI)
Table Major Company List of Selective Serotonin Reuptake Inhibitor (SSRI)
3.1.4 Tricyclic Antidepressants
Table Major Company List of Tricyclic Antidepressants
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Narcolepsy Therapeutics Market 2016-2020, by Type, in USD Million
Figure Global Narcolepsy Therapeutics Market Growth 2016-2020, by Type, in USD Million
Table Global Narcolepsy Therapeutics Market 2016-2020, by Type, in Volume
Figure Global Narcolepsy Therapeutics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Narcolepsy Therapeutics Market Forecast 2021-2026, by Type, in USD Million
Table Global Narcolepsy Therapeutics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Addrenex Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.1.1 Addrenex Pharmaceuticals, Inc. Profile
Table Addrenex Pharmaceuticals, Inc. Overview List
4.1.2 Addrenex Pharmaceuticals, Inc. Products & Services
4.1.3 Addrenex Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Addrenex Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Teva Pharmaceutical Industries Ltd. (Company Profile, Sales Data etc.)
4.2.1 Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Overview List
4.2.2 Teva Pharmaceutical Industries Ltd. Products & Services
4.2.3 Teva Pharmaceutical Industries Ltd. Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Jazz Pharmaceuticals PLC (Company Profile, Sales Data etc.)
4.3.1 Jazz Pharmaceuticals PLC Profile
Table Jazz Pharmaceuticals PLC Overview List
4.3.2 Jazz Pharmaceuticals PLC Products & Services
4.3.3 Jazz Pharmaceuticals PLC Business Operation Conditions
Table Business Operation of Jazz Pharmaceuticals PLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Graymark Healthcare, Inc. (Company Profile, Sales Data etc.)
4.4.1 Graymark Healthcare, Inc. Profile
Table Graymark Healthcare, Inc. Overview List
4.4.2 Graymark Healthcare, Inc. Products & Services
4.4.3 Graymark Healthcare, Inc. Business Operation Conditions
Table Business Operation of Graymark Healthcare, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Arena Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.5.1 Arena Pharmaceuticals, Inc. Profile
Table Arena Pharmaceuticals, Inc. Overview List
4.5.2 Arena Pharmaceuticals, Inc. Products & Services
4.5.3 Arena Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Arena Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 BIOPROJET (Company Profile, Sales Data etc.)
4.6.1 BIOPROJET Profile
Table BIOPROJET Overview List
4.6.2 BIOPROJET Products & Services
4.6.3 BIOPROJET Business Operation Conditions
Table Business Operation of BIOPROJET (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Shire (Company Profile, Sales Data etc.)
4.7.1 Shire Profile
Table Shire Overview List
4.7.2 Shire Products & Services
4.7.3 Shire Business Operation Conditions
Table Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Ligand Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.8.1 Ligand Pharmaceuticals, Inc. Profile
Table Ligand Pharmaceuticals, Inc. Overview List
4.8.2 Ligand Pharmaceuticals, Inc. Products & Services
4.8.3 Ligand Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Ligand Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Narcolepsy Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
Table Global Narcolepsy Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Narcolepsy Therapeutics Sales Revenue Share in 2020, by Company, in USD Million
Table Global Narcolepsy Therapeutics Sales Volume 2016-2020, by Company, in Volume
Table Global Narcolepsy Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Narcolepsy Therapeutics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Narcolepsy Therapeutics Market Concentration, in 2020
Figure Europe Narcolepsy Therapeutics Market Market Concentration, in 2020
Figure Asia-Pacific Narcolepsy Therapeutics MMarket Concentration, in 2020
Figure South America Narcolepsy Therapeutics Market Concentration, in 2020
Figure Middle East & Africa Narcolepsy Therapeutics Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Narcolepsy With Cataplexy
Figure Narcolepsy Therapeutics Demand in Narcolepsy With Cataplexy, 2016-2020, in USD Million
Figure Narcolepsy Therapeutics Demand in Narcolepsy With Cataplexy, 2016-2020, in Volume
6.1.2 Demand in Narcolepsy Without Cataplexy
Figure Narcolepsy Therapeutics Demand in Narcolepsy Without Cataplexy, 2016-2020, in USD Million
Figure Narcolepsy Therapeutics Demand in Narcolepsy Without Cataplexy, 2016-2020, in Volume
6.1.3 Demand in Secondary Narcolepsy
Figure Narcolepsy Therapeutics Demand in Secondary Narcolepsy, 2016-2020, in USD Million
Figure Narcolepsy Therapeutics Demand in Secondary Narcolepsy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Narcolepsy Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
Figure Narcolepsy Therapeutics Market Growth 2021-2026, by Application, in USD Million
Figure Narcolepsy Therapeutics Market Share in 2026, by Application, in USD Million
Table Narcolepsy Therapeutics Demand Forecast 2021-2026, by Application, in Volume
Table Narcolepsy Therapeutics Market Growth 2021-2026, by Application, in Volume
Table Narcolepsy Therapeutics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Narcolepsy Therapeutics Production 2016-2020, by Region, in USD Million
Table Narcolepsy Therapeutics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Narcolepsy Therapeutics Market 2016-2020, by Region, in USD Million
Table Global Narcolepsy Therapeutics Market Share 2016-2020, by Region, in USD Million
Table Global Narcolepsy Therapeutics Market 2016-2020, by Region, in Volume
Table Global Narcolepsy Therapeutics Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Narcolepsy Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure North America Narcolepsy Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
Table North America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Narcolepsy Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Europe Narcolepsy Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Europe Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Narcolepsy Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Narcolepsy Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Narcolepsy Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure South America Narcolepsy Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
Table South America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Narcolepsy Therapeutics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Narcolepsy Therapeutics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Narcolepsy Therapeutics Market Forecast 2021-2026, by Region, in USD Million
Table Narcolepsy Therapeutics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Figure
List of Table
List of Table
1. Table Upstream Segment of Narcolepsy Therapeutics
2. Table Application Segment of Narcolepsy Therapeutics
3. Table Global Narcolepsy Therapeutics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Sodium Oxybate
5. Table Major Company List of Selective Serotonin Reuptake Inhibitor (SSRI)
6. Table Major Company List of Tricyclic Antidepressants
7. Table Major Company List of Others
8. Table Global Narcolepsy Therapeutics Market 2016-2020, by Type, in USD Million
9. Table Global Narcolepsy Therapeutics Market 2016-2020, by Type, in Volume
10. Table Global Narcolepsy Therapeutics Market Forecast 2021-2026, by Type, in USD Million
11. Table Global Narcolepsy Therapeutics Market Forecast 2021-2026, by Type, in Volume
12. Table Addrenex Pharmaceuticals, Inc. Overview List
13. Table Business Operation of Addrenex Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Teva Pharmaceutical Industries Ltd. Overview List
15. Table Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Jazz Pharmaceuticals PLC Overview List
17. Table Business Operation of Jazz Pharmaceuticals PLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Graymark Healthcare, Inc. Overview List
19. Table Business Operation of Graymark Healthcare, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Arena Pharmaceuticals, Inc. Overview List
21. Table Business Operation of Arena Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table BIOPROJET Overview List
23. Table Business Operation of BIOPROJET (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Shire Overview List
25. Table Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Ligand Pharmaceuticals, Inc. Overview List
27. Table Business Operation of Ligand Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Global Narcolepsy Therapeutics Sales Revenue 2016-2020, by Company, in USD Million
29. Table Global Narcolepsy Therapeutics Sales Revenue Share 2016-2020, by Company, in USD Million
30. Table Global Narcolepsy Therapeutics Sales Volume 2016-2020, by Company, in Volume
31. Table Global Narcolepsy Therapeutics Sales Volume Share 2016-2020, by Company, in Volume
32. Table Regional Demand Comparison List
33. Table Major Application in Different Regions
34. Table Narcolepsy Therapeutics Demand Forecast 2021-2026, by Application, in USD Million
35. Table Narcolepsy Therapeutics Demand Forecast 2021-2026, by Application, in Volume
36. Table Narcolepsy Therapeutics Market Growth 2021-2026, by Application, in Volume
37. Table Narcolepsy Therapeutics Market Share in 2026, by Application, in Volume
38. Table Narcolepsy Therapeutics Production 2016-2020, by Region, in USD Million
39. Table Narcolepsy Therapeutics Production 2016-2020, by Region, in Volume
40. Table Global Narcolepsy Therapeutics Market 2016-2020, by Region, in USD Million
41. Table Global Narcolepsy Therapeutics Market Share 2016-2020, by Region, in USD Million
42. Table Global Narcolepsy Therapeutics Market 2016-2020, by Region, in Volume
43. Table Global Narcolepsy Therapeutics Market Share 2016-2020, by Region, in Volume
44. Table North America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
45. Table North America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
46. Table Europe Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
47. Table Europe Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
48. Table Asia-Pacific Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
49. Table Asia-Pacific Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
50. Table South America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
51. Table South America Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
52. Table Middle East & Africa Narcolepsy Therapeutics Market Size 2016-2020, by Country, in USD Million
53. Table Middle East & Africa Narcolepsy Therapeutics Market Size 2016-2020, by Country, in Volume
54. Table Narcolepsy Therapeutics Market Forecast 2021-2026, by Region, in USD Million
55. Table Narcolepsy Therapeutics Market Forecast 2021-2026, by Region, in Volume
56. Table Price Factors List